DSE:BXPHARMA

Beximco Pharmaceuticals PLC. announcements

297 Dhaka Stock Exchange announcements for Beximco Pharmaceuticals PLC. (BXPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2009 (38).

  1. The company has further informed that the 4,10,00,000 fully convertible, preference shares has been fully subscribed and

    The company has further informed that the 4,10,00,000 fully convertible, preference shares has been fully subscribed and allotted to the respective subscribers against their subscriptions.

  2. As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2009, the company has reported net prof

    As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2009, the company has reported net profit after tax of Tk. 480.69 m. with EPS of Tk. 3.18.

  3. The company has informed that SEC has accorded its Consent to Beximco Pharmaceuticals Ltd. for raising paid-up capital f

    The company has informed that SEC has accorded its Consent to Beximco Pharmaceuticals Ltd. for raising paid-up capital from Tk. 151,14,92,960.00 to Tk. 561,14,92,960.00 only through issuance up to 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 100 each amounting to Tk. 410,00,00,000.00. The issue will be open for subscription by the Shareholders of the company on 1st November 2009 and will be closed on 5th November 2009. The Offer Letters to the Shareholders of the company on the Record Date are being mailed to them to their respective addresses recorded with the company; and any Shareholder, not getting his/her Offer Letter within 31st October 2009 may also contact the share department at 17 Dhanmondi R/A, Road No. 1. Dhaka-1205.

  4. (continuation of news of BXPHARMA):10. An Information Memoranda will be used to facilitate investment in the aforesaid P

    (continuation of news of BXPHARMA):10. An Information Memoranda will be used to facilitate investment in the aforesaid Preference Share Issue.(b) The increase in the Authorised Share Capital of the Company from Tk. 200,00,00,000.00 to Tk. 910,00,00,000.00, consisting of 50,00,00,000 Ordinary Shares of Tk. 10 each amounting to Tk. 500,00,00,000.00; and 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 100 each amounting to Tk. 410,00,00,000.00 in view of the aforesaid Preference Share Issue; and to amend Clause-V of the Memorandum of Association and Article-4 of Articles of Association of the company for the said purpose.(end)

    The first part of this announcement is missing from the archive.
  5. (continuation of news of BXPHARMA):5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining

    (continuation of news of BXPHARMA):5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining 2,58,85,000 Preference Shares will be privately placed.6. Preference Shares will be issued on 1 November 2009 provided SEC's consent to the aforesaid Preference Share Issue is obtained prior to that date.7. There will be a one-year lock-in on the converted Ordinary Shares from the date of issue of the Preference Shares.8. The Preference Shares will not be listed and/or publicly placed. However, these will be transferable like any other shares. 9. The funds raised will be used for capital expenditures to finance ongoing BMRE projects and working capital of the company. (continue-4)

    The first part of this announcement is missing from the archive.
  6. (continuation of news of BXPHARMA): 2. Once Preference Shares are converted into Ordinary Shares; and lock-in period the

    (continuation of news of BXPHARMA): 2. Once Preference Shares are converted into Ordinary Shares; and lock-in period thereof expires, such ordinary shares shall be listed like other ordinary shares of the company in the stock exchanges and tradable thereat.3. An interim dividend at 2.5% for each quarter will be paid on 1 February 2010 and 2 May 2010 against the preference shares. Record date for interim dividend on Preference Shares shall be 31 January 2010 and 29 April 2010. 4. Shareholders on Record date on 17 September 2009 will have the prerogative to subscribe for 1,51,15,000 Preference Shares as above on a 10:1 basis, i.e., shareholders holding 10 existing Ordinary Shares will have the prerogative to subscribe for 1 Preference Share within 25 October 2009.(con.-3)

    The first part of this announcement is missing from the archive.
  7. (continuation of news of BXPHARMA)1. The Preference Shares shall be converted into Ordinary Shares in two stages.a. One-

    (continuation of news of BXPHARMA)1. The Preference Shares shall be converted into Ordinary Shares in two stages.a. One-half (50%), i.e., Taka 50, of each preference share will be converted into ordinary shares on 1 February 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 31 January 2010. b. and the remaining One-half (50%), i.e., Taka 50, of each preference share will be converted into ordinary shares on 2 May 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 30 April 2010. (continue-2)

    The first part of this announcement is missing from the archive.
  8. The company has further informed that the EGM of the company held on 15.10.09 at 11:00 AM have unanimously approved the

    The company has further informed that the EGM of the company held on 15.10.09 at 11:00 AM have unanimously approved the following:(a) Issuance upto 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 100 each amounting to Tk. 410,00,00,000.00, on the following terms and conditions: (continue-1)

  9. Normal trading of the shares of the company will resume on 27.09.09 after Record date for EGM.

    Normal trading of the shares of the company will resume on 27.09.09 after Record date for EGM.

  10. Trading of the shares of the company will remain suspended on record date i.e. 17.09.09 for EGM.

    Trading of the shares of the company will remain suspended on record date i.e. 17.09.09 for EGM.

  11. (continuation of Spot news of BXPHARMA)"Shareholders on Record date on 17 September 2009 will have the prerogative to su

    (continuation of Spot news of BXPHARMA)"Shareholders on Record date on 17 September 2009 will have the prerogative to subscribe for 1,51,15,000 Preference Shares as above on a 10:1 basis, i.e., shareholders holding 10 existing Ordinary Shares will have the prerogative to subscribe for 1 Preference Share within 25 October 2009" subject to approval of the shareholders in the EGM and SEC's consent.

    The first part of this announcement is missing from the archive.
  12. Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be

    Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle from 14.09.09 to 16.09.09. Trading of the shares of the company will remain suspended on record date i.e. 17.09.09 for EGM. It is to be noted here that the shareholders whose name will appear in the Share Register of the company or in the Depository Register on that date will be entitled to attend at the EGM. It is also to be mentioned here that as per serial no. 4 of the notice of the EGM of the company, (continue)

  13. continuation of news of BXPHARMA)10. An Information Memoranda will be used to facilitate investment in the aforesaid Pre

    continuation of news of BXPHARMA)10. An Information Memoranda will be used to facilitate investment in the aforesaid Preference Share Issue.II) To approve increase in the Authorised Share Capital of the Company shall be increased to Tk. 910,00,00,000.00, consisting of 50,00,00,000 Ordinary Shares of Tk. 10 each amounting to Tk. 500,00,00,000.00; and 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 100 each amounting to Tk. 410,00,00,000.00 in view of the aforesaid Preference Share Issue and to amend Clause-V of the Memorandum of Association and Articles of Association of the company for the said purpose.(end)

  14. (continuation of news of BXPHARMA)5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining

    (continuation of news of BXPHARMA)5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining 2,58,85,000 Preference Shares will be privately placed.6. Preference Shares will be issued on 1 November 2009 provided SEC's consent to the aforesaid Preference Share Issue is obtained prior to that date.7. There will be a one-year lock-in on the converted Ordinary Shares from the date of issue of the Preference Shares.8. The Preference Shares will not be listed and/or publicly placed. However, these will be transferable like any other shares. 9.The funds raised will be used for capital expenditures to finance ongoing BMRE projects and working capital of the company. (continue-4)

    The first part of this announcement is missing from the archive.
  15. (continuation of news of BXPHARMA) 2. Once Preference Shares are converted into Ordinary Shares; and lock-in period ther

    (continuation of news of BXPHARMA) 2. Once Preference Shares are converted into Ordinary Shares; and lock-in period thereof expires, such ordinary shares shall be listed like other ordinary shares of the company in the stock exchanges and tradable thereat. 3. An interim dividend at 2.5% for each quarter will be paid on 1 February 2010 and 2 May 2010 against the preference shares. Record date for interim dividend on Preference Shares shall be 31 January 2010 and 29 April 2010. 4. Shareholders on Record date on 17 September 2009 will have the prerogative to subscribe for 1,51,15,000 Preference Shares as above on a 10:1 basis, i.e., shareholders holding 10 existing Ordinary Shares will have the prerogative to subscribe for 1 Preference Share within 25 October 2009. (cont.-3)

    The first part of this announcement is missing from the archive.
  16. (continuation of news of BXPHARMA)1. The Preference Shares shall be converted into Ordinary Shares in two stages.a. One-

    (continuation of news of BXPHARMA)1. The Preference Shares shall be converted into Ordinary Shares in two stages.a. One-half (50%), i.e., Taka 50, of each preference share will be converted into ordinary shares on 1 February 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 31 January 2010. b. And the remaining One-half (50%), i.e., Taka 50, of each preference share will be converted into ordinary shares on 2 May 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 30 April 2010. (continue-2)

    The first part of this announcement is missing from the archive.
  17. The company has further informed that an EGM of the company will be held on 15.10.09 at 11:00 AM at BEXIMCO Industrial P

    The company has further informed that an EGM of the company will be held on 15.10.09 at 11:00 AM at BEXIMCO Industrial Park, Sarabo, Kashimpur, Gazipur to transect the following businesses as special business: I. To approve issuance upto 4,10,00,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 1,00 each subject to SEC's consent to the aforesaid preference share issue, on the following terms and conditions: (continue-1)

  18. (continuation of news of BXPHARMA)10. An Information Memoranda will be used to facilitate investment in the aforesaid Pr

    (continuation of news of BXPHARMA)10. An Information Memoranda will be used to facilitate investment in the aforesaid Preference Share Issue.11. In view of the aforesaid Preference Share Issue, the Authorised Share Capital of the Company shall be increased to Tk. 910,00,00,000.00, consisting of 50,00,00,000 Ordinary Shares of Tk. 10 each amounting to Tk. 500,00,00,000.00; and 4,100,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 1,000 each amounting to Tk. 410,00,00,000.00. (end)

    The first part of this announcement is missing from the archive.
  19. (continuation of news of BXPHARMA)5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining

    (continuation of news of BXPHARMA)5. The unsubscribed Preference Shares referred to in paragraph 4 above; and remaining 2,588,500 Preference Shares will be privately placed.6. Preference Shares will be issued on 1 November 2009 provided SEC's consent to the aforesaid Preference Share Issue is obtained prior to that date.7. There will be a one-year lock-in on the converted Ordinary Shares from the date of issue of the Preference Shares.8. The Preference Shares will not be listed and/or publicly placed. However, these will be transferable like any other shares. 9. The funds raised will be used for capital expenditures to finance ongoing BMRE projects and working capital of the company. (continue-4)

    The first part of this announcement is missing from the archive.
  20. (continuation of news of BXPHARMA)2. Once Preference Shares are converted into Ordinary Shares; and lock-in period there

    (continuation of news of BXPHARMA)2. Once Preference Shares are converted into Ordinary Shares; and lock-in period thereof expires, such ordinary shares shall be listed like other ordinary shares of the company in the stock exchanges and tradable thereat.3. An interim dividend at 2.5% for each quarter will be paid on 1 February 2010 and 2 May 2010 against the preference shares. Record date for interim dividend on Preference Shares shall be 31 January 2010 and 29 April 2010.4. Shareholders on Record date on 17 September 2009 will have the prerogative to subscribe for 1,511,500 Preference Shares as above on a 10:1 basis, i.e., shareholders holding 10 existing Ordinary Shares will have the prerogative to subscribe for 1 Preference Share within 25 October 2009. (continue)

    The first part of this announcement is missing from the archive.
  21. (continuation of news of BXPHARMA)1. The Preference Shares shall be converted into Ordinary Shares in two stages.a) One-

    (continuation of news of BXPHARMA)1. The Preference Shares shall be converted into Ordinary Shares in two stages.a) One-half (50%), i.e., Taka 500, of each preference share will be converted into ordinary shares on 1 February 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 31 January 2010.b) And the remaining One-half (50%), i.e., Taka 500, of each preference share will be converted into ordinary shares on 2 May 2010 at 25% discount to the weighted average price of the Dhaka Stock Exchange during the three-months ending 30 April 2010. (continue-2)

    The first part of this announcement is missing from the archive.
  22. The company has informed that the Board of Directors of the company in its meeting held on 02.09.09 at 5:00 PM reviewed

    The company has informed that the Board of Directors of the company in its meeting held on 02.09.09 at 5:00 PM reviewed the situation arising out of the imposition of lock-in on shares and warrants issuable to GEM Global Yield Fund Limited and subsequent non-receipt of fund from them. In view of this, the Board in its aforesaid meeting has decided to issue upto 4,100,000 Fully Convertible, 5% Dividend, Preference Shares of Taka 1,000 each on the following terms and conditions subject to approval of the shareholders of the company in their EGM to be held on 15.10.09 with Record Date on 17.09.09 at 11:00 AM at BEXIMCO Industrial Park, Sarabo, Kashimpur, Gazipur and SEC's consent to the aforesaid Preference Share Issue:- (continue-1)

  23. The Company has informed that the dividend warrants of the Company for the year 2008 have already been sent to the respe

    The Company has informed that the dividend warrants of the Company for the year 2008 have already been sent to the respective shareholders in their addresses recorded with the company by Courier Services on 12.08.09.

  24. As per un-audited half yearly accounts as on 30.06.09, the Company has reported profit after tax of Tk. 311.02 m with EP

    As per un-audited half yearly accounts as on 30.06.09, the Company has reported profit after tax of Tk. 311.02 m with EPS of Tk. 2.06 as against last year's half yearly of Tk. 151.45 m and Tk. 1.32 respectively.

  25. The company has informed that it has credited the Stock Dividend for the year 2008 to the respective shareholders' BO Ac

    The company has informed that it has credited the Stock Dividend for the year 2008 to the respective shareholders' BO Accounts on 22.06.09.

  26. Normal trading of the shares of the company will resume on 26.05.09 after Record date and there will be no price limit o

    Normal trading of the shares of the company will resume on 26.05.09 after Record date and there will be no price limit on the trading of the shares of the company for the same day.

  27. Trading of the shares of the company will remain suspended on record date i.e., 25.05.09.

    Trading of the shares of the company will remain suspended on record date i.e., 25.05.09.

  28. Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be

    Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 20.05.09 to 24.05.09. Trading of the shares of the company will remain suspended on record date i.e., 25.05.09.

  29. The company has informed that the Board of Directors has appointed Mr. Nazmul Hassan CEO as Managing Director of the Com

    The company has informed that the Board of Directors has appointed Mr. Nazmul Hassan CEO as Managing Director of the Company for a period of five years effective from 7th May 2009, subject to the consent of shareholders in the next AGM of the Company to be held on 16th June 2009.

  30. As per audited accounts as on 31.12.08, the Company has reported profit after tax of Tk. 545.34 m. with EPS of Tk. 4.33

    As per audited accounts as on 31.12.08, the Company has reported profit after tax of Tk. 545.34 m. with EPS of Tk. 4.33 as against Tk 353.07 m. and Tk. 2.80 (restated) respectively as on 31.12.07.

  31. (Repeat): There will be no price limit on the trading of the shares of the company today (03.05.09) following its corpor

    (Repeat): There will be no price limit on the trading of the shares of the company today (03.05.09) following its corporate declaration.

  32. (Repeat): The Board of Directors has recommended cash dividend @ 10% and stock dividend @ 20% for the year 2008. Date of

    (Repeat): The Board of Directors has recommended cash dividend @ 10% and stock dividend @ 20% for the year 2008. Date of AGM: 16.06.09, Time: 9:30 AM, Venue: 1, Shahbagh C/A, Dhaka. Record date: 25.05.09. The company has also reported that the Board has accepted report on valuation of Lands, Buildings and Plant & Machinery as of 31 December, 2008, issued by M/s. S. F. Ahmed & Co., Chartered Accountants and Valuer, showing an aggregate depreciated current cost of Tk. 5,485,286,356.00 resulting in a revaluations surplus aggregating Tk. 1,711,174,747.00

  33. There will be no price limit on the trading of the shares of the company on 03.05.09 following its corporate declaration

    There will be no price limit on the trading of the shares of the company on 03.05.09 following its corporate declaration.

  34. The Board of Directors has recommended cash dividend @ 10% and stock dividend @ 20% for the year 2008. Date of AGM: 16.0

    The Board of Directors has recommended cash dividend @ 10% and stock dividend @ 20% for the year 2008. Date of AGM: 16.06.09, Time: 9:30 AM, Venue: 1, Shahbagh C/A, Dhaka. Record date: 25.05.09. The company has also reported that the Board has accepted report on valuation of Lands, Buildings and Plant & Machinery as of 31 December, 2008, issued by M/s. S. F. Ahmed & Co., Chartered Accountants and Valuer, showing an aggregate depreciated current cost of Tk. 5,485,286,356.00 resulting in a revaluations surplus aggregating Tk. 1,711,174,747.00

  35. The company has informed that SEC has given consent, under the provisions of the Securities and Exchange Commission (Iss

    The company has informed that SEC has given consent, under the provisions of the Securities and Exchange Commission (Issue of Capital) Rules, 2001, for raising the paid-up capital from Tk. 125,95,77,470.00 up to Tk. 144,45,77,470.00 only through issuance of 1,60,00,000 Ordinary shares of Tk. 10.00 each at an issue price up to Tk. 312.50 per share (including a premium up to Tk. 302.50 each) and Warrant(s) to subscribe for a maximum 25,00,000 ordinary shares of Tk. 10.00 each at an issue price of Tk. 200.00 per share (including a premium of Tk. 190.00 each), totaling 1,85,00,000 ordinary shares of Tk. 10 each, through private placement with GEM Global Yield Fund Limited. The money so raised shall be used by the company for its BMRE, diversification and working capital.

  36. SEC has given consent to the company, under the provisions of the Securities and Exchange Commission (Issue of Capital)

    SEC has given consent to the company, under the provisions of the Securities and Exchange Commission (Issue of Capital) Rules, 2001, for raising the paid-up capital from Tk. 125,95,77,470.00 up to Tk. 144,45,77,470.00 only through issuance of 1,60,00,000 Ordinary shares of Tk. 10.00 each at an issue price up to Tk. 312.50 per share (including a premium up to Tk. 302.50 each) and Warrant(s) to subscribe for maximum 25,00,000 shares of Tk. 10.00 each at an issue price of Tk. 200.00 per share (including a premium of Tk. 190.00 each) through private placement with GEM Global Yield Fund Limited.

  37. The company has further informed that the EGM of the shareholders of the company held on 19.02.09 at 10:00 AM has approv

    The company has further informed that the EGM of the shareholders of the company held on 19.02.09 at 10:00 AM has approved issuance up to 16,000,000 ordinary shares having an anticipated value up to Tk. 4,100,000,000 at 90% of the market value thereof under Variable Pricing Method; and that of 2,500,000 warrants aggregating up to Tk. 500,000,000 at Tk. 200 per warrant to GEM Global Yield Fund Limited, totaling up to Tk. 18,500,000 ordinary shares having an anticipated value up to Tk. 4,600,000,000 under section 155(2) of the Companies Act, 1994 subject to the consent of SEC thereto under Securities and Exchange Commission (Issue of Capital) Rules, 2001. The moneys so raised shall be used by the company for its BMRE, diversification and working capital.

  38. The company has informed that the Board of Directors has approved issuance of ordinary shares aggregating up to Tk. 4,10

    The company has informed that the Board of Directors has approved issuance of ordinary shares aggregating up to Tk. 4,100,000,000 at 90% of the market value thereof under Variable Pricing Method; and that of warrants aggregating up to Tk. 500,000,000 at Tk. 200 per warrant/share to GEM Global Yield Fund Limited totaling Tk. 4,600,000,000 under section 155(2) of the Companies Act, 1994 subject to approval of its shareholders under the said section in their EGM to be held on 19.02.09 at 10:00 AM at 1, Shahbagh C/A, Dhaka; and the consent of the SEC under the Securities and Exchange Commission (Issue of Capital) Rules, 2001. The moneys so raised shall be used by the company for its BMRE, diversification and working capital.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.